How have CLABF shares performed in 2024?

Core One Labs' stock was trading at $0.2389 at the beginning of 2024. Since then, CLABF shares have decreased by 32.3% and is now trading at $0.1618. View the best growth stocks for 2024 here .

How do I buy shares of Core One Labs?

Shares of CLABF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CLABF

Core One Labs (CLABF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free CLABF Stock Alerts

$0.16

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $0.16
▼
$0.16
50-Day Range: $0.15
▼
$0.21
52-Week Range: $0.12
▼
$0.50

Volume: 127 shs
Average Volume: 4,838 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Core One Labs alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Core One Labs Stock (OTCMKTS:CLABF)

Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

CLABF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLABF Stock News Headlines

February 23, 2024 | finance.yahoo.com

Core One Labs Inc. (CLABF)

February 1, 2024 | morningstar.com

Core One Labs Inc

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

December 8, 2023 | finance.yahoo.com

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

December 1, 2023 | finance.yahoo.com

Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods

October 9, 2023 | msn.com

Halliburton And Core Laboratories Collaborate To Accelerate Digital Rock Data Solutions

September 1, 2023 | msn.com

New KU core laboratory enhances research for infectious disease

August 18, 2023 | finanznachrichten.de

Übersicht Suchergebnisse zum Thema CORE ONE LABS INC

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

August 16, 2023 | msn.com

Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up

August 4, 2023 | finance.yahoo.com

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's Disease

August 1, 2023 | finance.yahoo.com

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

July 28, 2023 | benzinga.com

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease

July 28, 2023 | finance.yahoo.com

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease

July 24, 2023 | benzinga.com

Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds

July 21, 2023 | finanznachrichten.de

Core One Labs Inc.: Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

July 21, 2023 | finance.yahoo.com

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

July 11, 2023 | finance.yahoo.com

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

July 7, 2023 | finanznachrichten.de

Core One Labs Inc.: Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method

July 7, 2023 | finance.yahoo.com

Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method

May 5, 2023 | finanznachrichten.de

Core One Labs Inc.: Core One in Talks with Multiple Companies to Supply Psilocybin

May 1, 2023 | finance.yahoo.com

Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

April 24, 2023 | msn.com

Core One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin

April 21, 2023 | finanznachrichten.de

Core One Labs Inc.: Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility

April 21, 2023 | finance.yahoo.com

Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility

March 31, 2023 | msn.com

Internet Crying Over Why Black Lab's Paw Prints Are Imprinted in Concrete

January 26, 2023 | msn.com

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

See More Headlines

Receive CLABF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:CLABF
CUSIP: N/A
CIK: 1640152
Web: core1labs.com
Phone: (866) 452-6731
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Joel Shacker (Age 33)
CEO & Director
Comp: $176.18k
Mr. Geoffrey Balderson (Age 46)
CFO, Secretary & Director
Comp: $29.7k
Dr. Santiago Ferro
Chief Medical Officer & Director
Mr. Brad Paul Eckenweiler (Age 70)
Founder & Advisor
Mr. Jan Burian Ph.D.
Chief Technical Officer
Dr. Elizabeth Matthews
Head of Scientific & Regulatory Affairs

Key Competitors

View All Competitors

CLABF Stock Analysis - Frequently Asked Questions

How have CLABF shares performed in 2024?: Core One Labs' stock was trading at $0.2389 at the beginning of 2024. Since then, CLABF shares have decreased by 32.3% and is now trading at $0.1618.
View the best growth stocks for 2024 here.
How do I buy shares of Core One Labs?: Shares of CLABF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLABF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Core One Labs (CLABF) Stock Price, News & Analysis

About Core One Labs Stock (OTCMKTS:CLABF)

CLABF Stock Price History

CLABF Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CLABF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info